Puncture microneedle device for precise administration through tympanic chamber of external auditory canal based on auxiliary propulsion
The microneedle device with a microneedle and propulsion element addresses the need for precise tympanic drug delivery, ensuring easy operation and accurate drug delivery for inner ear treatments, with low cost and high compliance.
Patent Information
- Application Number
- CN202411354635.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-26
- Publication Date
- 2024-12-10
AI Technical Summary
There is a lack of a puncture needle specifically designed for tympanic drug delivery via the external auditory canal, limiting precise drug delivery methods for treating inner ear diseases.
A microneedle device with an elongated microneedle element and propulsion element, featuring protrusions and a notch for precise penetration, a foldable fixing wing for stabilization, and a bifurcated double-branch structure for drug delivery, designed for easy operation and precise drug delivery through the external auditory canal and tympanic cavity.
The device is easy to operate, easy to fix, and has no adverse reactions, improving patient compliance and accuracy of sustained-release targeted drug delivery, suitable for large-scale production and application in treating inner ear diseases.
Smart Images

Figure CN119097832A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical devices, and in particular to a microneedle device for precise drug delivery and puncture through the external auditory canal tympanic cavity based on auxiliary propulsion. Background Art
[0002] At present, local treatment of inner ear diseases (such as deafness, tinnitus, vertigo, etc.) in clinical practice is mostly carried out by tympanic administration. Tympanic administration is a method of local treatment of inner ear diseases, mainly used in otology, especially for deafness, tinnitus and vertigo. This method directly delivers the drug to the tympanic cavity of the middle ear, allowing the drug to penetrate the round window membrane or oval window membrane, and then enter the perilymph of the inner ear, directly affecting the cochlea and vestibular organs.
[0003] There is no puncture needle designed specifically for tympanic drug delivery on the market. Therefore, it is desirable to develop a novel puncture needle device for tympanic drug delivery via the external auditory canal. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion, in view of the above-mentioned defects in the prior art, which is easy to operate and can achieve precise drug delivery.
[0005] According to the present invention, there is provided a microneedle device for precise drug delivery through the external auditory canal and tympanic cavity, comprising: an elongated microneedle element and an elongated propulsion element; wherein, at the front end of the elongated microneedle element inserted into the ear, a first protrusion, a second protrusion and a third protrusion are formed in sequence from the front end to the rear end, wherein the recessed portion between the first protrusion and the second protrusion is used to limit the position of the tympanic membrane when the first protrusion penetrates the tympanic membrane; an upward protrusion is formed at the front end of the elongated propulsion element, and the upward protrusion is sunken to form a notch, which is used to be clamped in the recessed portion between the second protrusion and the third protrusion of the elongated microneedle element, thereby controlling the insertion of the elongated microneedle element into the ear through the elongated propulsion element.
[0006] Preferably, the cross-sectional concave shape of the notch of the elongated advancing element matches the cross-sectional shape of the concave portion between the first protrusion and the second protrusion.
[0007] Preferably, the length of the notch of the elongated propulsion element along the extending direction of the elongated propulsion element is equal to the length of the recessed portion between the first protrusion and the second protrusion.
[0008] Alternatively, preferably, the length of the notch of the elongated propulsion element along the extending direction of the elongated propulsion element is 0.1-0.2 mm smaller than the length of the recessed portion between the first protrusion and the second protrusion.
[0009] Preferably, the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on assisted propulsion also includes: a foldable fixing wing located in the ear canal area of the elongated microneedle element when the first protrusion penetrates the eardrum, for fixing the position of the elongated microneedle element in the ear canal.
[0010] Preferably, the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on assisted propulsion according to a preferred embodiment of the present invention further includes: a control element arranged at the rear end of the elongated microneedle element for controlling the opening and folding of the foldable fixed wings.
[0011] Preferably, the microneedle device for precise drug delivery and puncture through the external auditory canal tympanic cavity based on assisted propulsion also includes: a forked double-branch structure located at the rear end of the elongated propulsion element, wherein the forked double-branch structure includes a three-way pipe, a first drug delivery unit and a second drug delivery unit, and the three openings of the three-way pipe are respectively connected to the main pipe of the elongated propulsion element, the first drug delivery unit and the second drug delivery unit.
[0012] Preferably, the rear end of the elongated propulsion element is provided with a handle which is angled with respect to the body of the elongated propulsion element.
[0013] Preferably, the length from the notch to the handle of the elongated pushing element is greater than the length from the second protrusion to the bifurcated double-branch structure of the elongated microneedle element.
[0014] Preferably, the first protrusion has a cross-sectional area that gradually decreases in a direction from back to front so as to penetrate the eardrum.
[0015] Preferably, the outer diameter of the main tube of the elongated microneedle element is in the range of 0.1 to 0.5 mm, and the inner diameter is in the range of 0.05 to 0.3 mm; the material of the elongated microneedle element is medical plastic or medical silicone; the material of the elongated propulsion element is medical hard plastic or stainless steel metal material, and the length of the main tube of the elongated microneedle element is in the range of 4.5 to 10 centimeters.
[0016] The present invention adopts a raised ultra-fine needle with three ribs at the front end, and is equipped with a propeller specially designed for microneedle implantation. In addition, a foldable fixing wing is added to the ear canal area of the microneedle for fixing the relative position in the ear canal, and a bifurcated double-branch structure is provided at the tail end of the microneedle to connect different drug delivery syringes, micropumps, drug delivery balloons, etc.
[0017] The invention is easy to operate, easy to fix, and has no adverse reactions such as obvious discomfort, which greatly improves the patient's compliance and the accuracy of sustained-release targeted drug delivery. At the same time, the invention has a low production cost and is suitable for large-scale production and promotion and application.
[0018] The invention is particularly suitable for local administration through the external auditory canal tympanic cavity, and has good application prospects and economic benefits for treating inner ear diseases such as deafness, tinnitus and vertigo. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] A more complete understanding of the present invention and its attendant advantages and features will be more readily appreciated by reference to the following detailed description taken in conjunction with the accompanying drawings, in which:
[0020] Figure 1 The overall schematic diagram of the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on assisted propulsion according to a preferred embodiment of the present invention is schematically shown.
[0021] Figure 2 A partial schematic diagram of a microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on assisted propulsion according to a preferred embodiment of the present invention is schematically shown.
[0022] It should be noted that the drawings are used to illustrate the present invention, rather than to limit the present invention. Note that the drawings showing the structures may not be drawn to scale. In addition, in the drawings, the same or similar elements are marked with the same or similar reference numerals. DETAILED DESCRIPTION
[0023] The technical solution of the present invention will be described clearly and completely below in conjunction with the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0024] In the description of the present invention, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc., indicating the orientation or positional relationship, are based on the orientation or positional relationship shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and cannot be understood as indicating or implying relative importance.
[0025] In the description of the present invention, it should be noted that, unless otherwise clearly specified and limited, the terms "installed", "connected", and "connected" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal communication of two components. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0026] In addition, the technical features involved in the different embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0027] Figure 1 The overall schematic diagram of the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on assisted propulsion according to a preferred embodiment of the present invention is schematically shown.
[0028] like Figure 1 As shown, the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to a preferred embodiment of the present invention comprises: an elongated microneedle element 10 and an elongated propulsion element 20.
[0029] Among them, the front end of the long microneedle element 10 inserted into the ear is sequentially formed with a first protrusion 11, a second protrusion 12 and a third protrusion 13 from the front end (ear entry end) to the rear end (hand-held end), wherein the cross-sectional area of the first protrusion 11 gradually decreases from the back to the front so as to penetrate the tympanic membrane, and the recessed portion between the first protrusion 11 and the second protrusion 12 is used to limit the position of the tympanic membrane when the first protrusion 11 penetrates the tympanic membrane.
[0030] An upward protrusion 21 is formed at the front end of the long strip propulsion element 20, and the upward protrusion 21 is recessed to form a notch for clamping in the recessed portion (such as the second protrusion 12 and the third protrusion 13) between the long strip microneedle element 10. Figure 2 The insertion of the elongated microneedle element 10 into the ear is controlled by the elongated propulsion element 20.
[0031] Preferably, the cross-sectional concave shape of the notch of the upward protrusion 21 of the elongated propulsion element 20 matches the cross-sectional shape of the concave portion between the first protrusion 11 and the second protrusion 12 .
[0032] Preferably, the length of the notch of the upper protrusion 21 of the elongated propulsion element 20 along the extending direction of the elongated propulsion element 20 is equal to the length of the recessed portion between the first protrusion 11 and the second protrusion 12. Alternatively, preferably, the length of the notch of the upper protrusion 21 of the elongated propulsion element 20 along the extending direction of the elongated propulsion element 20 is slightly smaller than the length of the recessed portion between the first protrusion 11 and the second protrusion 12, for example, the length of the notch of the upper protrusion 21 of the elongated propulsion element 20 along the extending direction of the elongated propulsion element 20 is 0.1-0.2 mm smaller than the length of the recessed portion between the first protrusion 11 and the second protrusion 12.
[0033] Preferably, if Figure 1As shown, according to a preferred embodiment of the present invention, the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on assisted propulsion also includes: a foldable fixing wing 14 located in the ear canal area of the elongated microneedle element 10 when the first protrusion 11 penetrates the eardrum, which is used to fix the position of the elongated microneedle element 10 in the ear canal.
[0034] Preferably, the microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to the preferred embodiment of the present invention further comprises: a control element (not specifically shown) arranged at the rear end (handheld end) of the elongated microneedle element 10 for controlling the opening and folding of the foldable fixing wings 14. Thus, when it is determined that the predetermined position in the ear canal has been reached, the foldable fixing wings 14 can be opened to fix the position of the elongated microneedle element 10 in the ear canal.
[0035] Furthermore, preferably, Figure 1 As shown, the microneedle device for precise drug delivery and puncture through the external auditory canal tympanic cavity based on assisted propulsion according to a preferred embodiment of the present invention also includes: a forked double-branch structure 15 located at the rear end (handheld end) of the elongated propulsion element 20, wherein the forked double-branch structure 15 includes a three-way pipe 16, a first drug delivery unit 17 and a second drug delivery unit 18, and the three openings of the three-way pipe 16 are respectively connected to the main pipe 19 of the elongated propulsion element 20, the first drug delivery unit 17 and the second drug delivery unit 17.
[0036] Preferably, if Figure 1 As shown, the rear end (hand-held end) of the elongated propulsion element 20 is provided with a handle 22 which is angled with the main body of the elongated propulsion element 20 to facilitate propulsion operation.
[0037] Preferably, the length from the upper protrusion 21 to the handle 22 of the elongated propulsion element 20 is greater than the length from the second protrusion 12 to the forked double-branch structure 15 of the elongated microneedle element 10, thereby allowing the user to operate the elongated propulsion element 20 more freely.
[0038] Preferably, the outer diameter of the microneedle body (main tube 19 of the long strip microneedle element 10) is in the range of 0.1 to 0.5 mm, and the inner diameter is in the range of 0.05 to 0.3 mm, that is, an ultrafine microneedle. The material of the long strip microneedle element 10 is, for example, medical plastic or medical silica gel; the material of the long strip propulsion element 20 is, for example, medical hard plastic or stainless steel metal material, and the length of the main tube of the long strip microneedle element is in the range of 4.5 to 10 cm.
[0039] The present invention adopts a raised ultra-fine needle with three ribs at the front end, and is equipped with a propeller specially designed for microneedle implantation. In addition, a foldable fixing wing is added to the ear canal area of the microneedle for fixing the relative position in the ear canal, and a bifurcated double-branch structure is provided at the tail end of the microneedle to connect different drug delivery syringes, micropumps, drug delivery balloons, etc.
[0040] The invention is easy to operate, easy to fix, and has no adverse reactions such as obvious discomfort, which greatly improves the patient's compliance and the accuracy of sustained-release targeted drug delivery. At the same time, the invention has a low production cost and is suitable for large-scale production and promotion and application.
[0041] The invention is particularly suitable for local administration through the external auditory canal tympanic cavity, and has good application prospects and economic benefits for treating inner ear diseases such as deafness, tinnitus and vertigo.
[0042] In addition, it should be noted that, unless otherwise specified, the terms "first", "second", "third", etc. in the specification are only used to distinguish the various components, elements, steps, etc. in the specification, and are not used to indicate the logical relationship or sequential relationship between the various components, elements, steps, etc.
[0043] It is to be understood that, although the present invention has been disclosed as a preferred embodiment, the above embodiment is not intended to limit the present invention. For any person skilled in the art, without departing from the scope of the technical solution of the present invention, the technical content disclosed above can be used to make many possible changes and modifications to the technical solution of the present invention, or modified into equivalent embodiments of equivalent changes. Therefore, any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the scope of protection of the technical solution of the present invention.
Claims
1. A microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion, characterized in that include: An elongated microneedle element and an elongated propulsion element; wherein, at the front end of the elongated microneedle element inserted into the ear, a first protrusion, a second protrusion and a third protrusion are formed in sequence from the front end to the rear end, wherein the recessed portion between the first protrusion and the second protrusion is used to limit the position of the tympanic membrane when the first protrusion penetrates the tympanic membrane; an upward protrusion is formed at the front end of the elongated propulsion element, and the upward protrusion is sunken to form a notch, which is used to snap into the recessed portion between the second protrusion and the third protrusion of the elongated microneedle element, so as to control the insertion of the elongated microneedle element into the ear through the elongated propulsion element.
2. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1, characterized in that: The cross-sectional concave shape of the notch of the elongated advancing element matches the cross-sectional shape of the concave portion between the first protrusion and the second protrusion.
3. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that: The length of the notch of the elongated propulsion element along the extending direction of the elongated propulsion element is equal to the length of the recessed portion between the first protrusion and the second protrusion.
4. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that: The length of the notch of the elongated propulsion element along the extending direction of the elongated propulsion element is 0.1-0.2 mm smaller than the length of the recessed portion between the first protrusion and the second protrusion; And / or, the cross-sectional area of the first protrusion gradually decreases in the direction from back to front so as to penetrate the eardrum.
5. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that It also includes: a foldable fixing wing located in the ear canal area of the elongated microneedle element when the first protrusion penetrates the eardrum, and is used to fix the position of the elongated microneedle element in the ear canal.
6. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 5, characterized in that The invention also comprises: a control element arranged at the rear end of the long strip-shaped microneedle element and used for controlling the opening and folding of the foldable fixed wings.
7. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that It also includes: a forked double-branch structure located at the rear end of the long strip propulsion element, wherein the forked double-branch structure includes a three-way pipe, a first dosing unit and a second dosing unit, and the three openings of the three-way pipe are respectively connected to the main pipe of the long strip propulsion element, the first dosing unit and the second dosing unit.
8. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that: The rear end of the elongated propulsion element is provided with a handle which is angled with the main body of the elongated propulsion element.
9. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that: The length from the notch to the handle of the elongated pushing element is greater than the length from the second protrusion to the bifurcated double-branch structure of the elongated microneedle element.
10. The microneedle device for precise drug delivery through the external auditory canal tympanic cavity based on auxiliary propulsion according to claim 1 or 2, characterized in that: The outer diameter of the main tube of the elongated microneedle element is in the range of 0.1 to 0.5 mm, and the inner diameter is in the range of 0.05 to 0.3 mm; the material of the elongated microneedle element is medical plastic or medical silicone; the material of the elongated propulsion element is medical hard plastic or stainless steel metal material, and the length of the main tube of the elongated microneedle element is in the range of 4.5 to 10 centimeters.
Citation Information
Patent Citations
Earplug type tympanic administration device
CN110613888A
Micro-needle intratympanic injection dosing device
CN115737279A
Single-channel multi-angle puncture system
CN213883428U
Trainage-tube propeller for imbedding tympanic membrane
CN2287971Y
Needle guide for remedying otitis media
KR1020120115739A
